portulacerebroside A

has antineoplastic activity; isolated from Portulaca oleracea; structure in first source

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Leukemia 01/01/2016 - "This study aimed to explore the effect of portulacerebroside A (PCA) on the adhesion, migration, and invasion in human leukemia HL60 cells and U937 cells and clarify the possible mechanisms involved, which could provide potential strategies for the treatment of AML. " 01/01/2023 - "Portulacerebroside a Inhibits Adhesion, Migration, and Invasion of Human Leukemia HL60 Cells and U937 Cells through the Regulation of p38/JNK Signaling Pathway [Retraction]." 01/01/2016 - "Portulacerebroside A inhibits adhesion, migration, and invasion of human leukemia HL60 cells and U937 cells through the regulation of p38/JNK signaling pathway." 01/01/2015 - "We aimed at exploring the effect of portulacerebroside A (PCA) on the apoptosis in human leukemia HL60 cells and clarify the possible mechanisms involved in. " 01/01/2015 - "Effects of portulacerebroside a on apoptosis of human leukemia HL60 cells and p38/JNK signaling pathway."
2.	Neoplasm Metastasis (Metastasis) 05/01/2015 - "Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A."
3.	Liver Neoplasms (Liver Cancer) 05/01/2015 - "Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A."